Felületes hólyagdaganatok intravesicalis BCG instillációjával elért eredményeink.

Translated title of the contribution: Results obtained by intravesical instillation of BCG in superficial bladder tumors

I. Romics, B. Dietmar, R. Christoph

Research output: Contribution to journalReview article

Abstract

The authors carried out immunotherapy in bladder cancer patients in stage pTa-1 G1-2 NoMo. The strain Connaught BCG (120 mg) was instilled weekly for 6 consecutive weeks in 26 patients. Another 13 patients were treated with 150 mg BCG strain Pasteur. The patients were followed average 26 months in the first, 16 months in the second group. The recurring of the tumor were found in 26% and 15% as well. Side effects were experienced more often in the third group. The authors advice the BCG therapy of the superficial bladder cancer.

Translated title of the contributionResults obtained by intravesical instillation of BCG in superficial bladder tumors
Original languageHungarian
Pages (from-to)25-28
Number of pages4
JournalOrvosi hetilap
Volume131
Issue number1
Publication statusPublished - Jan 7 1990

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Results obtained by intravesical instillation of BCG in superficial bladder tumors'. Together they form a unique fingerprint.

  • Cite this